What is the main business of Salt Labs?

The main business activity of Salt Labs focuses on manufacture of homogenised food preparations and dietetic food.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 4, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Frezerów 2, 20-209 Lublin.

What is the share capital?

The share capital of the company is PLN 500,000 (approx. $135,062).

What period do the latest financial data cover?

The latest available financial statement covers the period from November 28, 2024 to December 31, 2025.

What revenue was generated?

The company reported a revenue of USD 250,359 in 2025.

No, in 2025 the company was not profitable, reporting a net loss of USD 340,981.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to USD 445,196 in 2025, representing 77% of all operating expenses.

Salt Labssp. z o.o.

Manufacture of homogenised food preparations and dietetic food

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-12-04

Share capital

500,000.00 PLN

Registered address

ul. Frezerów 2, 20-209 Lublin, Poland

Electronic delivery address

AE:PL-45647-15162-RDIWA-17

Financials

Financial insight

The statement flags a going concern risk.

From the notes

Current income tax (CIT due)

Filing timeliness

The financial statement for 2025 was filed on time.

202530/04/2026

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of homogenised food preparations and dietetic food45 / 72

Top 63%

Division · Manufacture of food products2,586 / 3,381

Top 76%

Sector · Manufacturing17,298 / 24,460

Top 71%

City · Lublin2,274 / 4,863

Top 47%

Voivodeship · Lubelskie5,260 / 10,226

Top 51%

Country · Poland155,247 / 297,873

Top 52%

Results vs industry

Revenue

This companyUSD 250.36kMedianUSD 483.69kAverageUSD 6.69m

Net profit

This companyUSD -340.98kMedianUSD 12.34kAverageUSD 535.92k

Operating costs

This companyUSD 574.73kMedianUSD 492.39kAverageUSD 5.88m

Assets

This companyUSD 379.12kMedianUSD 421.84kAverageUSD 5.96m

Industry

Authorized Representatives

Grzegorz Stefan Mróz – Attorney-in-fact

Marcin Jakub Pogroszewski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Marcin Jakub Pogroszewskiage 39	6,459	$87,236.63	64.59%
Others	3,541	$47,825.50	35.41%

The articles of association require company consent for share transfers.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2025-01-20.

mBank
70 1140 1094 0000 7126 6700 1002
mBank
97 1140 1094 0000 7126 6700 1001
mBank
16 1140 1094 0000 7126 6700 1004

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Erbafarm Naturalesp. z o.o.	$574,147.77	erbafarm.pl
Epicgreensp. z o.o.	$181,308.02	epicgreen.pl
Natura Organicasp. z o.o.	$128,773.68	naturaorganica.pl
Propharmsp. z o.o.	$25,859.81	propharm.pl
Vianatsp. z o.o.	$20,652.52	vianat.eu
Vasco Techsp. z o.o.	$18,452.60	vascotech.pl
Symbio PolskaS.A.	$9,938.92	symbio.pl
BEE & Sonssp. z o.o.	$8,782.50	beeandsons.com
Noblepharma Bissp. z o.o.	$0.19	noblepharma.pl
Taorasp. z o.o.	$0.08	taora.pl